Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.

Autor:	Velayutham NK; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Thamaraikani T; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Wahab S; Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia., Khalid M; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia., Ramachawolran G; Department of Foundation, RCSI and UCD Malaysia Campus, George Town, Malaysia., Abullais SS; Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha, Saudi Arabia., Wong LS; Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia., Sekar M; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia.; Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India., Gan SH; School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia., Ebenezer AJ; Trichy Research Institute of Biotechnology Pvt Ltd., Trichy, Tamil Nadu, India., Ravikumar M; Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India., Subramaniyan V; Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor, Malaysia., Izzati Mat Rani NN; Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, Malaysia., Wu YS; Department of Biological Sciences and Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, Subang Jaya, Selangor, Malaysia., Jeyabalan S; Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India.
Jazyk:	angličtina
Zdroj:	Frontiers in pharmacology [Front Pharmacol] 2024 Jan 17; Vol. 15, pp. 1343756. Date of Electronic Publication: 2024 Jan 17 (Print Publication: 2024).
DOI:	10.3389/fphar.2024.1343756
Abstrakt:	[This corrects the article DOI: 10.3389/fphar.2023.1150270.]. Competing Interests: Author AE was employed by Trichy Research Institute of Biotechnology Pvt Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. (Copyright © 2024 Velayutham, Thamaraikani, Wahab, Khalid, Ramachawolran, Abullais, Wong, Sekar, Gan, Ebenezer, Ravikumar, Subramaniyan, Izzati Mat Rani, Wu and Jeyabalan.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu